Literature DB >> 2786733

Antioxidant enzymes in lymphocytes from normal subjects and patients with chronic lymphocytic leukaemia: increased glutathione peroxidase activity in CLL B lymphocytes.

C M Farber1, D N Kanganis, L F Liebes, R Silber.   

Abstract

The activities of several enzymes that protect against oxidative injury were determined in blood lymphocytes from patients with B chronic lymphocytic leukaemia (CLL) and from normal subjects. Similar glutathione reductase (GR), catalase and glucose-6-phosphate dehydrogenase (G6PD) activities were found in normal and CLL lymphocytes. Higher glutathione peroxidase (GP) activity was found in CLL lymphocytes. This activity in CLL B lymphocytes was 2-fold higher than that of normal B lymphocytes, and 3-fold higher than that of T lymphocytes from either source. Several disease processes have been associated with decreased glutathione peroxidase activity. Our finding with CLL B lymphocytes is believed to be the first example of an increased GP activity in a disease. It may reflect either the expansion of a rare type of B cell population or be an expression of the malignant process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786733     DOI: 10.1111/j.1365-2141.1989.tb07647.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.

Authors:  Sabyasachi Biswas; Xiaobin Zhao; Andrew P Mone; Xiaokui Mo; Melissa Vargo; David Jarjoura; John C Byrd; Natarajan Muthusamy
Journal:  Leuk Res       Date:  2010-02-19       Impact factor: 3.156

2.  Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".

Authors:  Neil E Kay; Tait D Shanafelt; Ann K Strege; Yean K Lee; Nancy D Bone; Azra Raza
Journal:  Leuk Res       Date:  2007-01-22       Impact factor: 3.156

3.  Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues.

Authors:  R A Nagourney; J C Messenger; D H Kern; L M Weisenthal
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 4.  Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.

Authors:  Mary E Irwin; Nilsa Rivera-Del Valle; Joya Chandra
Journal:  Antioxid Redox Signal       Date:  2012-09-28       Impact factor: 8.401

5.  Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.

Authors:  Dunyaporn Trachootham; Hui Zhang; Wan Zhang; Li Feng; Min Du; Yan Zhou; Zhao Chen; Helene Pelicano; William Plunkett; William G Wierda; Michael J Keating; Peng Huang
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

6.  Characterization of three B-cell lymphoma cell lines from chemotherapy resistant patients with respect to in vitro sensitivity to 21 antitumor agents, ABC-transporter expression and cellular redox status.

Authors:  Karin Bracht; Thomas Kiefer; Gottfried Dölken; Patrick J Bednarski
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-12       Impact factor: 4.553

Review 7.  Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies.

Authors:  Mareike Kelkel; Claus Jacob; Mario Dicato; Marc Diederich
Journal:  Molecules       Date:  2010-10-12       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.